1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. doi:10.3322/caac.21654
2. Filho AM, Laversanne M, Ferlay J, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336-1346. doi:10.1002/ijc.35278
3. Mahdy H, Vadakekut ES, Crotzer D. Endometrial cancer. In: StatPearls. StatPearls Publishing; 2024.
4. Huang WL, Huang KH, Huang CY, et al. Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study. BMC Urol. 2020;20(1):117. doi:10.1186/s12894-020-00684-5
5. Bryce C, Gazda R, Fuerst H. Endometrial cancer: rapid evidence review. Am Fam Physician. 2025;111(6):526-531.
6. Zeng X, Xu C, Cheng J, et al. Poor glycemic control might compromise the efficacy of chemotherapy in non-small cell lung cancer patients with diabetes mellitus. Cancer Med. 2020;9(3):902-911. doi:10.1002/cam4. 2750
7. Jiang L, Okada A, Ishida R, Yasunaga H. Association between metabolic syndrome and incident cervical cancer: a retrospective cohort study. J Obes. 2025;2025:3691654. doi:10.1155/jobe/3691654
8. Liang SH, Shen YC, Wu JY, et al. Impact of poor preoperative glycemic control on outcomes among patients with cervical cancer undergoing a radical hysterectomy. Oncol Res Treat. 2020;43(1-2):10-18. doi:10.1159/ 000502911
9. Lai SW, Liao KF. New-onset diabetes mellitus and the risk of pancreatic cancer. J Gastroenterol Hepatol. 2025;40(1):341. doi:10.1111/jgh.16801
10. Li L, Li F, Pan Z. A Mendelian randomization study of type 2 diabetes and cancer risk in East Asians. Cancer Cell Int. 2025;25(1):295. doi:10. 1186/s12935-025-03929-1
11. Zhao J, Hu Y, Zhao Y, et al. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments. BMC Womens Health. 2021;21(1):312. doi:10.1186/s12905-021-01452-9
12. Wang L, Du ZH, Qiao JM, Gao S. Association between metabolic syndrome and endometrial cancer risk: a systematic review and meta-analysis of observational studies. Aging (Albany NY). 2020;12(10):9825-9839. doi:10.18632/aging.103247
13. Byrne FL, Martin AR, Kosasih M, et al. The role of hyperglycemia in endometrial cancer pathogenesis. Cancers (Basel). 2020;12(5):1191. doi: 10.3390/cancers12051191
14. Wang Y, Zeng X, Tan J, et al. Diabetes mellitus and endometrial carcinoma: risk factors and etiological links. Medicine (Baltimore). 2022;101(34):e30299. doi:10.1097/MD.0000000000030299
15. Yang X, Wang J. The role of metabolic syndrome in endometrial cancer: a review. Front Oncol. 2019;9:744. doi:10.3389/fonc.2019.00744
16. Sidorkiewicz I, Józwik M, Niemira M, Kretowski A. Insulin resistance and endometrial cancer: emerging role for microRNA. Cancers (Basel). 2020;12(9):2559. doi:10.3390/cancers12092559
17. Bikle DD. Vitamin D: production, metabolism, and mechanism of action. In: Feingold KR, ed. Endotext. MDText.com, Inc.; 2025.
18. Agic A, Xu H, Altgassen C, et al. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007;14(5):486-497. doi:10.1177/1933719107304565
19. Wang K, Dong F, Ma S, Bu Z. The association between vitamin D deficiency and clinical pregnancy rate in IVF patients with different age. Front Endocrinol (Lausanne). 2025;15:1485238. doi:10.3389/fendo.2024. 1485238
20. Guo J, Liu S, Wang P, et al. Characterization of VDR and CYP27B1 expression in the endometrium during the menstrual cycle before embryo transfer: implications for endometrial receptivity. Reprod Biol Endocrinol. 2020;18(1):24. doi:10.1186/s12958-020-00579-y
21. Liu JJ, Bertrand KA, Karageorgi S, et al. Prospective analysis of vitamin D and endometrial cancer risk. Ann Oncol. 2013;24(3):687-692. doi:10. 1093/annonc/mds509
22. An HJ, Song DH. Displacement of vitamin D receptor is related to lower histological grade of endometrioid carcinoma. Anticancer Res. 2019; 39(8):4143-4147. doi:10.21873/anticanres.13573
23. Zebalski MA, Zebalska P, Krzywon A, Nowosielski K. Vitamin D concentration among women with gynecological cancers. Cancers (Basel). 2025;17(12):1987. doi:10.3390/cancers17121987
24. Duman İ, Tiftik RN, Ün İ. Effects of vitamin D analogs alfacalcidol and calcitriol on cell proliferation and migration of HEC1A endometrial adenocarcinoma cells. Nutr Cancer. 2021;73(2):273-281. doi:10.1080/01635581.2020.1764066
25. Badary DM, Abou-Taleb H. Vitamin D receptor and cellular retinol-binding protein-1 immunohistochemical expression in normal, hyperplastic and neoplastic endometrium: possible diagnostic and therapeutic implications. Ann Diagn Pathol. 2020;48:151569. doi:10. 1016/j.anndiagpath.2020.151569
26. Hu Y, Zhu C, Qin Y, et al. Serum 25(OH)D levels and risk of female-specific cancer in premenopausal women: a prospective study. Front Nutr. 2025;12:1617565. doi:10.3389/fnut.2025.1617565
27. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(suppl 1):S20-S42. doi:10.2337/dc24-S002
28. Correction to: “Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.” J Clin Endocrinol Metab. 2024;109(10):e1991. doi:10.1210/clinem/dgae373
29. Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet. 2023;162(2):383-394. doi:10.1002/ijgo.14923
30. Ohanoglu Cetinel K, Guner G, Karabudak CB, Zeynalli E, Yavuz Sen S. Dynamic changes in prognostic nutritional index and systemic immune-inflammation index predict survival following debulking surgery in ovarian cancer. Front Oncol. 2026;15:1720075. doi:10.3389/fonc.2025.1720075
31. Yeniocak AS, Salman S, Kumbasar S, Tercan C. Overdiagnosis of endometrium cancer: a retrospective study. J Acad Res Med. 2023;13(2): 88-94. doi:10.4274/jarem.galenos.2023.85047
32. Korpe B, Kose C, Erdogan K, et al. Preoperative hemoglobin A1c as a predictor of lymph node metastasis in diabetic women with endometrial cancer. Adv Clin Exp Med. 2025;34(9):1451-1457. doi:10.17219/acem/ 198152
33. Ling S, Sweeting M, Zaccardi F, et al. Glycosylated haemoglobin and prognosis in 10,536 people with cancer and pre-existing diabetes: a meta-analysis with dose-response analysis. BMC Cancer. 2022;22(1):1048. doi: 10.1186/s12885-022-10144-y
34. Kuznia S, Zhu A, Akutsu T, et al. Efficacy of vitamin D3 supplementation on cancer mortality: systematic review and individual patient data meta-analysis of randomised controlled trials. Ageing Res Rev. 2023;87:101923. doi:10.1016/j.arr.2023.101923
35. Neale RE, English DR, McLeod DS, et al. The effect of vitamin D supplementation on cancer incidence in the randomised controlled D-Health Trial: implications for policy and practice. J Steroid Biochem Mol Biol. 2025;250:106738. doi:10.1016/j.jsbmb.2025.106738